You need to sign in or sign up before continuing.
💰 Financial Record
paymentTransaction Details
Payer (From)
Public Market
Linked to Public Market
Payee (To)
Synageva BioPharma/NLV-II
Linked to Synageva BioPharma/NLV-II
Transaction Date
November 01, 2011
Description
Reverse merger to become public; exited at 7.3x
Additional Details
Date string:
November, 2011
Amount string:
Source document:
HOUSE_OVERSIGHT_024045.jpg
📄 Source Document
HOUSE_OVERSIGHT_024045.jpg
ESTATE Collection
Document Summary
This document is a confidential investment report page (marked House Oversight) detailing the track record of New Leaf Ventures (NLV) in the biopharmaceutical sector. It highlights their investment strategy, networking capabilities, and specific performance metrics (multiples on invested capital) for various portfolio companies across funds NLV-I, NLV-II, and Sprout Funds. The text lists specific exits and IPOs occurring between 2011 and 2013.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein financial record